The ability of neutrophils to phagocytize and then kill ingested bacteria is critical for mammalian resistance to pathogenic Inicrobes. Facultative intracellular bacteria such as Mycobacterium tuberculosis, Brucella abortus, and Listeria monocytogenes have evolved mechanisms to circumvent these processes. A wide variety of virulence factors which alter phagocytic cell function have been discussed (9) . Included with these factors are a cell wall component of B. abortus (20, 21) and sulfolipids of M. tuberculosis (12, 13) . The demonstrated effector molecule is frequently secreted or located on the bacterial surface which is first exposed to the phagocytic cell.
B. abortus is ingested by neutrophils but does not stimulate the oxidative burst (20) . It inhibits neutrophil degranulation and is resistant to some granule-released antimicrobial enzymes (24) . However, B. abortus is sensitive to the myeloperoxidase-H20rhalide system (20) . A cell wallassociated lipopolysaccharide has been proposed as the cell wall component that is the key virulence factor which inhibits neutrophil degranulation (20, 21) . Recently, a nucleotidelike compound has been isolated from the surface of virulent B. abortus and is capable of inhibiting protein iodination (a measure of the myeloperoxidase-H20rhalide pathway) by bovine neutrophils (7) . The protein iodination reaction is dependent on a number of neutrophil processes including phagocytosis, production of H20 2, release of myeloperoxidase from primary granules, and the presence of halide ions (19) . The B. abortus extract did not inhibit Staphylococcus aureus phagocytosis or superoxide anion production, but it does inhibit the iodination reaction. Since adequate amounts of protein and iodide were present, it was speculated that the reduced iodination was a result of Brucella extract-mediated inhibition of degranulation.
For intracellular degranulation to occur, the membranes of the phagosome and lysosome must fuse. Release of granule enzymes for the activation of oxygen-dependent (myeloperoxidase-H202-halide system) or oxygen-independent (proteases, cationic proteins, phospholipase A~ pathways is necessary for Inicrobicidal activity by the neutrophil (1, 28) . Neutrophil degranulation is inhibited by exogenous cAMP, cAMP analogs, and various agents which increase intracellular cAMP levels (10, 15, 17, 18) . Most studies have shown that primary and secondary granule release is inhibited by these materials.
Secretion of both primary and secondary granules is promoted by opsonized zymosan (16) . Secondary granules of rabbit neutrophils degranulate as early as 30 s after phagocytosis, and primary granules degranulate 1 to 3 Inin after phagocytosis (3) . Preferential degranulation of secondary granules has been demonstrated with phorbol myristate acetate or the ionophore A23187 (30) . The purpose of this study was to exainine the ability of a nucleotidelike material isolated from B. abortus (7) to inhibit bovine neutrophil degranulation and to determine whether there was any preferential inhibition of primary or secondary granule release from neutrophilic leukocytes.
MATERIALS AND MEmODS
Preparation of B. abortus and Brucella extract. Bacteria for extract isolation were prepared as previously described (7) . B. abortus 2308 (a highly virulent, smooth form of bovine origin) was grown in a fermentor for 48 h at 37°C. The bacteria were harvested by filtration and washed three times with sterile 0.85% saline by centrifugation. They were heat killed at 65°C for 60 min and pelleted by centrifugation at 18,000 x g for 20 min. Supernatant from the heat-killed bacteria was collected and separated into two fractions by molecular filtration (YM2 filters; Ainicon Corp., Lexington, Mass.). The YM-2 filter has a nominal molecular mass cutoff of 1,000 daltons, a clear water flow of 0.02 to 0.035 mVcm 2 per min at a pressure of 3.8 kg/cm 2 , and a solute rejection of 40% for sucrose, 65% for raffinose, and 80% for inulin (Ainicon). Material retained by the filter was considered as having a molecular mass greater than 1,000 daltons, and the filtrate was arbitrarily designated as less than 1,000 daltons. The filtered extract was separated by high-performance liquid chromatography to remove salts and lyophilized to remove volatile ·buffer components. The remaining dried material was weighed directly, and the active components contained no detectable lipids or proteins (7) . The extract passing through the 1,000-dalton molecular mass filter was tested at three concentrations.
Neutrophll leukocyte preparation. Four adult HolsteinFriesian steers, serologically negative for B. abortus, were used as a source of polymorphonuclear leukocytes (PMNs) for this study. Bovine PMNs were isolated as previously described (25) . Peripheral blood was collected in acidcitrate-glucose solution and centrifuged. The resulting plasma and buffy-coat cells were aspirated and discarded, and erythrocytes present in the packed cell layer were lysed with hypotonic phosphate-buffered, deionized water. ,Isotonicity. was restored to the remaining cells (90% or greater being granulocytes) by addition of phosphatebuffered (0.0132 M, pH 7.2) 2.7% saline (PBS). Granulocytes were washed, resuspended in PBS to a concentration of 5 x 10 7 cells per ml, and held at room temperature for approximately 1 h before use.
PMN function test. The iodination assay (19, 25) was conducted in duplicate, and the average of duplicate values was used for calculations. The assay (a measure of the myeloperoxidase-H20rhalide system of PMNs) was performed in capped polystyrene tubes (12 by 75 mm). The standard reaction mixture contained 0.05 ml ofPMNs (2.5 x 106 cells), 0.05 JJ.Ci of 125 1 (carrier-free; Amersham Corp., Arlil\gton Heights, Ill.), 40 nmol ofNal, 0.05 ml ofpreopsonized zymosan (10 mg/ml), and 0.3 ml of Earle balanced salt solution. Results were standardized and expressed as nanomoles of Nal per 10 7 PMNs per hour. One hundred microliters of each of the three different Brucella extract concentrations was added to the standard reaction mixture, resulting in final Brucella fraction concentrations of 0.04, 0.16, and 0.32 mg/ml (wt/vol). The approximate number of bacteria required to produce each concentration was 2.5 x 1()9/ml (0.04 mg/ml), 1 X 10 10 /ml (0.16 mg/ml), and 2 X 10 10 /ml (0.32 mg/ml). This extract was collected from killed cells only, but B. abortus may be able to release the materials present in the extract without cell lysis and death (7). To determine the total possible degranulation and iodination in the test system, 100 JJ.l of PBS was added to the mixture instead of Brucella extract. To determine the minimum level of iodination and degranulation in the system, no zymosan was added to the reaction mixture (unstimulated neutrophils). The reaction in each test group was allowed to proceed for 20 min at 37°C, and the amount of trichloroacetic acid-precipitable radioactivity was determined. Results were expressed as nanomoles of Nal per 10 7 PMNs per hour.
Sample preparation for electron microscopy. Duplicate samples for electron microscopic examination were prepared simultaneously with samples for the iodination assays.
Sodium iodide was used in place of Na 125 1 for electron microscopic samples. At the end of the 20-min incubation period, cold WC) 2.5% glutaraldehyde in 0.1 M cacodylate buffer was added to the reaction mixture, and fixation was allowed to proceed for 3 h: Neutrophils were fixed while in suspension and at 4°C so microtubules would depolymerize and the cells would become spherical. Samples were then postfixed in 1.0% Os04 for 30 min, dehydrated in graded alcohols, cleared in propylene oxide, embedded, and polymerized in resin. Ultrathin sections were cut at 70 to 90 nm and stained with uranyl acetate and lead citrate.
Identification of primary granules was done as previously reported (22) . Neutrophils were fixed in 2.5% glutaraldehyde, washed in cacodylate buffer, and suspended in the peroxidase substrate of Graham and Karnovsky (14) . Perox- Morphometric analysis. Analysis was conducted as previously described (4, 6, 29) . Six to 10 blocks were made, and 1 block was randomly chosen from each duplicate sample. Ten photomicrographs were obtained by random systematic subsampling at a magnification of x6,900. Photographs were made at a final magnification of x 18,000. For morphometric analysis, a point count lattice (121 points) was superimposed on photographs, and points falling on phagolysosome, nucleus, and primary (peroxidase positive) and secondary (peroxidase negative) granules were recorded. Points on other structures within the neutrophil were also recorded for determining total cell points. The percentage of the neutrophil occupied by each of these structures was calculated as previously described (4, 6, 29) . If the total cell points (excluding those on phagolysosomes) are used as the reference compartment, point-to-point ratios of a given organelle to the total cell will be the relative volume percent (Vv) of that organelle within that cell (6, 29) . Abbreviations used to describe morphometric data are found in Table 1 .
To determine absolute areas for absolute volume determination, neutrophil and nuclear profile areas were measured by semiautomatic, computerized morphometry (Bioquant II; R&M Biometrics, Nashville, Tenn.). Since neutrophils were induced to become spherical, mensuration coefficients can be used to calculate the actual volume of a neutrophil from the cross-sectional area (28) by the following equations:
where A,. is the cross-sectional area of the neutrophil, D is the diameter of the neutrophil, and Vyc is the neutrophil volume. By multiplying the actual neutrophil volume (VTC) by the volume percent (V v) of a given organelle, the actual volume (V) for that organelle can be determined (4, 6, 29) . The relative volume percent of primary granules (Vv..,J was determined on peroxidase-labeled, unstained thin sections. These sections were then stained with uranyl acetate and lead citrate, and the relative volume percents of all granules (Yvtg) and of the zymosan-containing phagosomes (Yvp.> were determined. The relative volume of secondary • V ,., Secondary granule (peroxidase negative) volume; slope = 21.2 (not significant).
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granules was calculated by:
where Yvsa is the relative volume of secondary granules. Inhibited degranulation of all granules was calculated as a percentage of PBS-treated neutrophil V ta<V tgls) by:
where V tglp is the V ta of the given principal group. Inhibited degranulation of primary granules was calculated as a percentage of PBS-treated neutrophil V 1111 (V aa~J by:
where V agtp is the V 1111 of a given principal group. Inhibited degranulation of secondary granules was calculated as a percentage of PBS-treated neutrophil v., (V.g~J by: (6) where Ysgtp is the v., of any given principal group. The ratio of primary to secondary granule volumes was calculated by:
V agtp/Ysgtp (7) Statistical analysis. Linear regression analysis was used to statistically determine the influence of Brucella fraction concentration on protein iodination, granule volume, and percent inhibition of neutrophil degranulation. All slopes were tested against the hypothesis that there was no difference from zero. Student's t test was used to statistically determine differences between groups in the volume of zymosan-containing phagolysosomes and primary and secondary granules.
RESULTS
Inhibition of granule release. Unstimulated neutrophilic leukocytes were considered to have the maximal granule volume possible for animals in these experiments and to have released no granules. Granule volume (V ta> represented 26% of the neutrophil volume (VTd. with most of that being peroxidase-negative (secondary) granules (Table 2) . Neutrophils exposed to saline and opsonized zymosan were considered to have the maximal amount of degranulation possible with our test system and 0.0% inhibition of granule release. The number of granule profiles was markedly reduced compared with unstimulated neutrophils, and the total granule volume (Vta> was 10% of the neutrophil volume (VTd (Table 2 ). The volume ratio of primary (V ...> to secondary (V.g) granules was greater in neutrophils exposed to saline and zymosan than that seen in unstimulated neutrophils ( Table 2 ). Approximately 36% of the volume of all granules (V ta> was released from neutrophils in this group. Most of the released granule volume was the result of secondary granule release (Table 2 ). Neutrophils exposed to the Brucella extract and opsonized zymosan had significant (P < 0.002) concentration-dependent inhibition of primary granule release, and inhibition of primary granule release was greatest in neutrophils treated with 0.32 mg of Brucella extract per ml and zymosan (Fig. 1) .
Morphometry of neutrophilic leukocyte granules. Neutrophilic leukocytes exposed to the lowest extract concentration had granule volumes similar to those in neutrophils exposed to saline and zymosan ( Table 2 ). The ratio of primary (Vag) to secondary (V5g) granule volume in neutrophils exposed to 0.16 mg of Brucella extract per ml was greater than that in unstimulated neutrophils. The volume of primary granules <Vag) was greater (P < 0.05), but the volume of secondary granules (V5g) was not different (P > 0.05) from that in neutrophils treated with saline and zymosan ( Table 2 ). Neutrophils exposed to 0.32 mg of Brucella extract per ml had a greater V1g than saline-treated neutrophils but less than that in unstimulated neutrophils.
The volume of primary (Vag) granules was significantly (P < 0. 05) greater, but the volume of secondary granules (V sg) was not significantly (P > 0.05) different from that of neutrophils treated with saline and zymosan. The volume ratio of primary <Vag) to secondary <Vsg) granules in this group was greater than that from neutrophils treated with 0.16 mg of Brucella extract per ml and zymosan (Table 2) .
NeutrophUic leukocyte morphology. Unstimulated neutrophilic leukocytes were round with few cytoplasmic projections (Fig. 2) . Granules were located in and around the centrosome and separated from the plasma membrane by a thin rim of organelle-free cytoplasm. In peroxidase-labeled, unstained sections, peroxidase-positive (primary) granules had a punctate, electron-dense precipitate which was confined to the granule cross-sectional profile (Fig. 3) . These granules were variably sized, round to oblong, and randomly distributed in the cell. The average cut surface area (mean ± the standard error of the mean) of neutrophils was 40.7 ± 1.1 1J.m 2 and 4.5 ± 0.3 IJ.m 2 for the nucleus, which gave the mensuration values in Table 3 .
Neutrophilic leukocytes exposed to saline and opsonized zymosan were round to ovoid and had multiple pseudopodia. The average neutrophil profile area was 42.8 ± 2.3 IJ.m 2 , and the nucleus profile area was 4.1 ± 0.1JLm 2 (Table 3) . One to I several phagolysosomes were in most neutrophils, and each contained one to several zymosan particles. The mean volume of phagolysosomes (Vp1) was not statistically greater than that of those from Brucella extract-treated neutrophils (Table 3) .
Neutrophils exposed to the lowest concentration (0.04 mg/ml) of Brucella extract had a neutrophil cross-sectional area of 44.3 ± 2.4 JLm 2 and a nuclear cross-sectional area of 4.4 ± 0.7 JLm 2 (Table 3) . Neutrophils--had -multiple pseudopodia and reduced granulation (Fig. 4) . Phagolysosomes containing one to several zymosan particles had a volume (V~1) of 3.8 11-m 3 , which was not significantly greater than that in the other groups.
Neutrophils exposed to 0.16 mg of Brucella extract per ml and zymosan had an average neutrophil cross-sectional area of 44.4 ± 2.4 1J.iD 2 and a nuclear cross-sectional area of 4.3 ± 0.6 11-m 2 (Table 3) . One to several zymosan-containing phagolysosomes were present in most neutrophils. The volume of zymosan-containing phagolysosomes (Vp1) was not statistically different from that in the other groups (Table  3) . Granules were polarized, with most located away from and a few juxtaposed to phagolysosomes.
Neutrophils exposed to 0.32 mg of Brucella extract per ml and zymosan had an average cross-sectional area of 45.7 ± 0.8 11-m 2 and a nuclear cross-sectional area of 4.0 ± 0.3 11-m 2 ( Table 3) . Phagolysosome volume (Vp1) was not significantly different (Table 3 ) from that in the other groups, and there was no significant concentration effect on this volume (P > 0.41). Some granules had a flocculent matrix and a crosssectional profile similar to that of primary granules (Fig. 5) .
Protein iodination. Neutrophilic leukocytes exposed to saline and opsonized zymosan were considered to have the maximal amount of protein iodination (myeloperoxidaseH20rhalide activity) possible with our test system. A concentration-dependent decrease in iodination was present in neutrophils exposed to the Brucella extract, and this decrease paralleled the inhibition of primary granule release. At the two highest concentrations of extract, protein iodination was significantly less than that in neutrophils exposed to saline and zymosan only. preferential inhibition of neutrophil degranulation was dose dependent. Phorbol myristate acetate and ionophore A23187 cause preferential release of neutrophil secondary granules (11, 30) by their ability to increase cellular levels of cGMP (11) . The increase in cellular cyclic nucleotides is seen only after a period of phorbol myristate acetate-neutrophil incubation (11) . Activity of the Brucella extract used in the present study has been attributed to nucleotidelike com- pounds (7), and in the present study its inhibitory effects occurred without a preincubation period with the neutrophil. This immediate effect on neutrophils suggests the Brucella fraction works at a different cellular location· than phorbol myristate acetate or directly substitutes for a nucleotide that may control neutrophil granule release. Purine nucleotides and modified analogs inhibit zymosan-stimulated lysosomal secretion from macrophages (23) . This Brucella fraction may be part~ally responsible for the inhibition of neutrophil degranulation seen with live B. abortus (20) .
Reduced neutrophil degranulation and preferential inhibition of primary granule release are not explained by inhibition of zymosan phagocytosis. Phagolysosomal volumes were reduced in a dose-dependent manner for each of the Brucella-treated groups, but this reduction was not statistically significant. Furthermore, Brucella extract does not inhibit ingestion of Staphylococcus aureus by bovine neutrophils (7). Inhibition of protein iodination could be the result of inhibited neutrophil myeloperoxidase activity, but this is not likely since similar concentrations of Brucella extract did not reduce in vitro peroxidase activity (7) .
Preferential inhibition of primary granule release suggests that different mech(lnisms control release of the two granule types from bovine neutrophils. Granules are released from rabbit neutrophils at different times during the process of degranulation (3) . The sequential release is coordinated with a pH change in the phagosome which provides optimal activity of the granule enzymes. These and other (11, 30) observations support the notion that there is selective control of neutrophil degranulation, yet most inhibitors of degranulatio'n block both primary and secondary granule release (10, 15, 17, 18, 31) . The preferential inhibition of primary granule release by Brucella extract was concentration dependent. This suggests that the ~xtract inhibits a different pathway from that which controls secondary granule release or has a dose-<J~pendent ejfect on the same pathway that controls release of both granules from neutrophils.
B. abortus is phagocytized by neutrophils without activation of the hexose monophosphate pathway (20) and inhibits neutrophil degranulation (24) . A cell waU component, possibly lipopolysaccharide, was proposed as the mediator of these effects on human and guinea pig neutrophils (24) . The concentrations of Brucella fraction used in our study have been demonstrated to inhibit the protein iodination reaction of bovine neutrophils, and this same activity has been demonstrated with live B. abortus (7) . Results of the present study demonstrate that this fraction also preferentially inhibits neutrophil primary granule release. These studies indicate that B. abor(us has at least two components which inhibit neutrophil degranulation: a lipopolysaccharide (20, 21) and a nucleotidelike material. Similar results as those obtained in the present study could be obtained with a lipopolysaccharide preparation if it were contaminated with the nucleotide-
